AIH Therapy for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to examine how sleep apnea (a sleep disorder with breathing interruptions) and low oxygen levels affect muscle strength and lung function in individuals with long-term spinal cord injuries. Participants will use an AIH mask, which creates short bursts of low oxygen, to assess its potential impact. The trial includes two groups: one with moderate to severe sleep apnea and another without sleep apnea. Eligible participants must have had a spinal cord injury for at least a year, a neck injury between C5 and C8, and must breathe comfortably at rest, as indicated by a specific oxygen level in their blood. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance understanding and treatment of spinal cord injuries.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the AIH mask and Induced Acute Intermittent Hypoxia (AIH) are safe for individuals with spinal cord injury?
Research has shown that the AIH mask treatment, which uses Induced Acute Intermittent Hypoxia (AIH), is generally safe. Studies have found that AIH helps the body adjust without affecting brain function or its blood supply, meaning it doesn't interfere with cognitive processes or cerebral circulation.
The treatment has been tested in various situations, such as hand exercises and walking training. Results showed improvements in hand use and walking, with no major safety issues reported. These findings suggest that AIH is well-tolerated and can be safely used to aid rehabilitation, such as enhancing muscle strength and lung function, particularly for individuals with spinal cord injuries.
Overall, the evidence supports AIH as a safe therapy option, making it a promising treatment for further exploration.12345Why are researchers excited about this trial?
Researchers are excited about AIH therapy for spinal cord injury because it offers a novel approach by using an AIH mask to induce acute intermittent hypoxia. Unlike current treatments that primarily focus on rehabilitation and medication to manage symptoms, AIH therapy aims to enhance neural plasticity and improve motor function by exposing patients to controlled, brief periods of low oxygen. This unique mechanism could potentially kick-start the body's ability to repair and adapt, leading to improved outcomes for those with spinal cord injuries.
What evidence suggests that AIH therapy could be effective for spinal cord injury?
Research has shown that a treatment called acute intermittent hypoxia (AIH) might help people with spinal cord injuries. In this trial, participants will be divided into two groups: those with moderate to severe obstructive sleep apnea (OSA) and those without OSA. Studies have found that just one session of AIH can increase grip and pinch strength, with the best results seen about three hours after treatment. Some evidence also suggests that AIH might improve breathing in people with long-term spinal cord injuries. It may work by changing how nerve cells activate, leading to stronger muscles. These early findings are promising, indicating that AIH could be a useful tool in rehabilitation.25678
Who Is on the Research Team?
Shirin Shafazand, MD
Principal Investigator
University of Miami
Are You a Good Fit for This Trial?
This trial is for adults over 18 with chronic, non-progressive spinal cord injury (SCI) at least one year post-injury. Participants must have an Asia Impairment Scale of C or D, a cervical injury between C5-C8, and normal oxygen levels. It's not for hospitalized individuals, those with recent heart issues, pregnant women, prisoners, people unable to consent or currently on airway pressure therapy for sleep apnea.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline measurements of motor function and biomarker levels are taken
Intervention
Participants undergo intermittent hypoxia sessions to assess effects on motor function and biomarkers
Follow-up
Participants are monitored for changes in motor function and biomarker levels post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- AIH mask
- Induced Acute Intermittent Hypoxia (AIH)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
The Craig H. Neilsen Foundation
Collaborator